Close mobile menu×

Claudia A. Chiriboga-Klein, MD, MPH

Board Certifications: 
Child Neurology, Neurology With Special Qualifications In Child Neurology
Accepting New Patients
Treats Children
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 342-6867

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Child Neurology
  • Neurology With Special Qualifications In Child Neurology

Clinical Expertise

  • Developmental Disorder
  • Headache
  • Migraines
  • Movement Disorder

Specialties

Education & Training

  • University of Buenos Aires Medical School
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: St Lukes Roosevelt Hospital

About Claudia Chiriboga-Klein

Dr. Chiriboga is Professor of Neurology and Pediatrics at CUMC and former Interim Director of the Division of Child Neurology, Departments of Neurology and Pediatrics, College of Physicians and Surgeons of Columbia University. She is also former Chief of Pediatric Neurology at Columbia University's affiliate hospital, Harlem Hospital Center.

Dr. Chiriboga was born in Peru and educated in Argentina, where she graduated with Honors from the Faculty of Medicine at the National University of Buenos Aires in 1982. Dr. Chiriboga completed training in pediatrics at St. Luke's-Roosevelt Hospital in 1985. After completing her training in child neurology in 1988 at the Neurological Institute and Babies Hospital of Columbia-Presbyterian Medical Center, Dr. Chiriboga joined the Division of Child Neurology at NewYork-Presbyterian/Columbia University Medical Center. Subsequently, she completed a Neuroepidemiology fellowship at the Gertrude H. Sergievsky Center and received a Master in Public Health from the Mailman School of Public Health, Columbia University. Dr. Chiriboga serves/has served on committees of the NIH, CNS, and ABPN. She is a diplomate of the ABPN in Child Neurology.

Dr. Chiriboga's current research focuses on Spinal Muscular Atrophy (SMA) clinical trials. Past areas of research, including NIH funding, has focused on congenital infections and neurodevelopmental disorders, including cerebral palsy and effects of perinatal exposures. Her clinical practice focuses on neuromuscular disorders as well as developmental, neurobehavioral neurology, and migraine, and on the treatment of spasticity.

Academic Titles

  • Professor of Neurology and Pediatrics (in the Gertrude H. Sergievsky Center) at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Languages

  • Spanish

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Access (Exchange)
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

MagnaCare

Medicare

  • Medicare

Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • EPO
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • SelectHealth

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
Harkness Pavilion
180 Fort Washington Avenue
New York, NY 10032
Primary

Research

Dr. Chiriboga's clinical research, including NIH funding, has focused on congenital infections and neurodevelopmental disorders, including cerebral palsy and effects of perinatal exposures. Her clinical practice focuses on developmental, neurobehavioral neurology and migraine and on the treatment of spasticity.

Grants

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, SHAM-PROCEDURE CONTROLLED STUDY TO ASSESS THE CLINICAL EFFICACY AND SAFETY OF ISIS 396443 ADMINISTERED INTRATHECALLY IN PATIENTS WITH LATER-ONSET SPINAL MUSCULAR ATROPHY (P&S Industry Clinical Trial)

Nov 14 2014 - Nov 14 2019

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, SHAM-PROCEDURE CONTROLLED STUDY TO ASSESS THE CLINICAL EFFICACY AND SAFETY OF ISIS 396443 ADMINISTERED INTRATHECALLY IN PATIENTS WITH INFANTILE-ONSET SPINAL MUSCULAR ATROPHY (P&S Industry Clinical Trial)

Aug 14 2014 - Aug 14 2019

AN OPEN-LABEL STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF ISIS 396443 IN PATIENTS WITH SPINAL MUSCULAR ATROPHY WHO PREVIOUSLY PARTICIPATED IN ISIS 396443-CS2 OR ISIS 396443-CS10 (P&S Industry Clinical Trial)

Jan 23 2014 - Jan 23 2019

SPINAL MUSCULAR ATROPHY (SMA) BIOMARKERS IN THE IMMEDIATE POSTNATAL PERIOD OF DEVELOPMENT NN101 (Federal Gov)

Sep 30 2011 - Aug 31 2018

SPINAL MUSCULAR ATROPHY (SMA) BIOMARKERS IN THE IMMEDIATE POSTNATAL PERIOD OF DEVELOPMENT NN101 (Federal Gov)

Sep 30 2011 - Aug 31 2018

COLUMBIA UNIVERSITY MEDICAL CENTER-WEILL CORNELL MEDICAL CENTER NEXT SITE (Federal Gov)

Sep 30 2011 - Jun 30 2018

A STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF MULTIPLE DOSES OF ISIS 396443 DELIVERED INTRATHECALLY TO PATIENTS WITH INFANTILE-ONSET SPINAL MUSCULAR ATROPHY. (P&S Industry Clinical Trial)

Jun 4 2013 - Jun 4 2018

ISIS (P&S Industry Clinical Trial)

Dec 2 2011 - Dec 2 2016

SMA FOUNDATION CENTER GRANT (Private)

Jul 1 2015 - Dec 31 2015

PEDIATRIC NEUROMUSCULAR CLINICAL RESEARCH NETWORK FOR SMA (Private)

Jul 1 2012 - Jun 30 2015

COLUMBIA SMA PROJECT: 4-AP AS A POTENTIAL SMA THERAPEUTIC AGENT AND BIOLOGICAL MECHANISMS OF ACTION (Federal Gov)

Sep 1 2011 - Aug 31 2014